Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
about
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infectionEscherichia coli heat-labile detoxified enterotoxin modulates dendritic cell function and attenuates allergic airway inflammationChronic restraint stress induces severe disruption of the T-cell specific response to tetanus toxin vaccineNeutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate.Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens.Gut as the largest immunologic tissue.Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells.Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissueTh17 cytokines and vaccine-induced immunity.Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activationVaccines for mucosal immunity to combat emerging infectious diseases.Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax.Improving vaccine performance with adjuvants.Intranasal immunization confers protection against murine Pneumocystis carinii lung infectionEffectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in miceExpression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.Immunoglobulin responses at the mucosal interface.Genetically manipulated bacterial toxin as a new generation mucosal adjuvant.Immunomodulation using bacterial enterotoxins.Mucosal immune network in the gut for the control of infectious diseases.HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen.Nasal immunization with homogenate and peptide antigens induces protective immunity against Trichinella spiralisIntranasal coadministration of the Cry1Ac protoxin with amoebal lysates increases protection against Naegleria fowleri meningoencephalitis.A revisit of mucosal IgA immunity and oral tolerance.Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.Deficient induction of the immune response to oral immunization with cholera toxin in malnourished rats during sucklingInnate signaling networks in mucosal IgA class switchingThe biology of intestinal immunoglobulin A responsesPeyer's patches are required for oral tolerance to proteins.Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virusPlasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.
P2860
Q24548763-A140602B-EFD6-446D-AF71-58717B855F08Q27318601-45C95E4F-3C0C-4B56-B9FB-5EBDBA9667BCQ28347439-4B97C6C7-DFE7-4ED3-9F52-3D2E7738654AQ30417262-F8FC963E-F221-4D33-B33F-F655A72B6A8DQ33429006-3E3C1F2E-C668-4994-9C5D-149A46EDB553Q33731530-315889F3-D448-4B63-A5C9-289E3CD53D34Q33767936-692BE6CD-2608-4919-9E51-5D8C79888F81Q33768109-03BE09E3-8E57-42E9-83E6-9620BEEB08ACQ33768922-D4FB822B-D6A7-4652-973F-DE57948168A8Q33769366-0D1312C4-CB37-4D9C-B0AA-9318B02ACDF3Q33792227-1E62CCD3-1CEB-4724-A64C-CE485570E7CBQ33849144-4E448B14-3925-4AC5-BD33-3BAA9B867B54Q33853571-0DB1D410-636B-4D04-A8E0-3775D53EC877Q33870830-87097D96-7CF0-47D0-9066-9B811B312DB7Q33883311-E6688571-B4AC-4928-8BC6-14C2BF83BCD4Q33886205-30945902-6328-4FC8-AD90-34503EA1B6BAQ33935005-79FE4153-95A6-48A5-9AC2-26956EEB19B7Q33956247-6FDD8603-4F18-4A1B-9CCE-EC4D17EF4859Q34000349-F4CB3F7B-FBDB-4F94-8EF7-08E2E1489966Q34000362-725F6875-5276-4F8B-93F7-15D3692EA520Q34002455-B0A0EC36-193C-4944-A9B8-31667D5374DBQ34002657-A840BBD9-1137-4BE5-9B4E-8F4B67A60932Q34006327-A41F31FF-8237-45F7-A57F-3FBA88BBEE0EQ34006359-E4F7E4D5-4ED3-434B-AFEA-90A32BC6684AQ34025272-98580E96-7580-4649-AC00-C13E6C01E486Q34184890-89C1AEA2-3F4E-4B70-BA57-0E61A07AD24AQ34184898-CE504D63-CC0C-4C5E-8A92-0AC6639000B1Q34191806-B236EC6F-6FEA-4192-B439-C749F441572AQ34238526-661BC384-6940-4A0C-8D19-1C02FFACF470Q34258467-8C836321-2472-4454-BB2E-C0BB1AD7D21AQ34335523-3DD31EA7-F48C-4A9D-A9D9-827C6EB5B3F2Q34419871-59607848-923F-46E6-BAFB-83DC1CB266ADQ34522227-A61E3055-C663-4638-B7B1-78A744AF6C12Q34544650-5E9EEF8E-C925-42F3-94B5-D6EF8642A911Q34614189-EA59EC3B-698B-4327-8BD1-2ACD38BA0AB8Q34673861-84F2A3B0-AEF5-4A97-B180-E1D4BE07052AQ34725322-B96079D4-EB28-4093-BE87-F43B1F6A9B55Q34744920-2A0DEC77-059B-4A21-A637-D082C5577F72Q34998726-C688B142-64D1-4090-85AA-602817411CC3Q35012034-966BC970-50DF-440A-BFE7-54F171806828
P2860
Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Helper T cell subsets for immu ...... in mucosa associated tissues.
@en
type
label
Helper T cell subsets for immu ...... in mucosa associated tissues.
@en
prefLabel
Helper T cell subsets for immu ...... in mucosa associated tissues.
@en
P2093
P2860
P356
P1476
Helper T cell subsets for immu ...... in mucosa associated tissues.
@en
P2093
H F Staats
J R McGhee
J Xu-Amano
K Fujihashi
P D Burrows
R J Jackson
P2860
P304
P356
10.1084/JEM.178.4.1309
P407
P577
1993-10-01T00:00:00Z